Insulet (PODD) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | 41.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.26% |
| Dec 31, 2025 | 53.76% |
| Sep 30, 2025 | 188.19% |
| Dec 31, 2022 | 17.87% |
| Sep 30, 2022 | -44.20% |
| Dec 31, 2019 | 59.38% |
| Sep 30, 2019 | 31.48% |
| Jun 30, 2019 | 64.04% |
| Mar 31, 2019 | 34.70% |
| Dec 31, 2018 | 37.33% |
| Sep 30, 2018 | 30.35% |
| Jun 30, 2018 | 28.78% |
| Dec 31, 2017 | -32.04% |
| Sep 30, 2017 | 34.99% |
| Jun 30, 2017 | 19.22% |
| Mar 31, 2017 | -36.14% |
| Dec 31, 2016 | -164.89% |
| Sep 30, 2016 | 29.75% |
| Mar 31, 2016 | -20.39% |
| Dec 31, 2015 | -38.91% |
| Sep 30, 2015 | -29.62% |
| Jun 30, 2015 | -17.52% |
| Mar 31, 2015 | 6.74% |
| Dec 31, 2014 | 28.77% |
| Sep 30, 2014 | 28.20% |
| Jun 30, 2014 | 26.02% |
| Mar 31, 2014 | 46.76% |
| Dec 31, 2013 | 27.15% |
| Sep 30, 2013 | -26.50% |